Enhanced Genomics ('Enhanced' or 'the Company'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for co ...
SANTA CLARA, MD, UNITED STATES, January 5, 2026 /EINPresswire.com/ — OmicInsight Corporation (hereinafter “OmicInsight”), a pioneer in AI-driven high-sensitivity spatial omics analysis, today ...
As part of the collaboration, Lilly and Revvity will jointly fund access for selected participants, including access to Signals One and Signals Xynthetica software offerings and modeling credits. This ...
Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
This collaboration combines real world clinical EMR data from a large footprint of cancer centers with research grade multi-omics data collected at key treatment timepoints. These data and linked ...
Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures ...
SHANGHAI, April 15, 2024 /PRNewswire/ -- The9 Limited (NCTY) ("The9"), an established Internet company, today announced that its investee WM Therapeutics Co., Ltd. (未名脑脑) ("WM Therapeutics") has ...
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback